Abstract

Colorectal cancer is the second cause of death in Spain (20% diagnosed in stage IV), improving survival in recent years thanks to chemotherapy and metastatic surgeries. With regard to a patient diagnosed with native stage IV KRAS colon adenocarcinoma (peritoneal, hepatic), the subject of cytoreduction with HIPEC (intraperitoneal hyperthermic chemotherapy) and the factors that influence the tumor response are reviewed.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call